期刊文献+

内镜治疗远端恶性胆道梗阻的现状

Current status of endoscopic treatment of distal malignant biliary obstruction
下载PDF
导出
摘要 由于远端恶性胆道梗阻症状的隐匿性和肿瘤较强的侵袭能力,当发现胆道梗阻时患者往往错过了最佳的外科手术时机,以提高生活质量为目的的姑息治疗成为目前主流的治疗方式。随着内镜技术和支架技术的发展,新型支架及内镜技术在姑息治疗的应用越来越多。作者就内镜下姑息治疗的优势、操作方法、支架选择、相关并发症及最新内镜下治疗方式等方面作一综述。 Because of the concealment of the symptoms of distal malignant biliary obstruction and the strong invasive ability of the tumor,patients often miss the best surgical opportunity when biliary obstruction is found.Palliative treatment for the purpose of improving the quality of life has become the mainstream treatment at present.With the development of endoscopic technology and stent technology,new stents and endoscopic techniques are used more and more in palliative treatment.The authors reviewed the advantages,operating methods,stent selection,related complications and the latest endoscopic treatment methods of endoscopic palliative treatment.
作者 刘治达 宋吉涛 陈晶 LIU Zhida;SONG Jitao;CHEN Jing(The Second Clinical Hospital Affiliated to Harbin Medical University,Heilongjiang Harbin 150080,China)
出处 《现代肿瘤医学》 CAS 北大核心 2023年第16期3131-3134,共4页 Journal of Modern Oncology
关键词 胆道梗阻 内镜逆行胰胆管造影 胆道支架 biliary obstruction endoscopic retrograde cholangiopancreatography biliary stent
  • 相关文献

参考文献4

二级参考文献36

  • 1Miguel Angel Suarez-Munoz,Jose Luis Fernandez-Aguilar,Belinda Sanchez-Perez,Jose Antonio Perez-Daga,Beatriz Garcia-Albiach,Ysabel Pulido-Roa,Naiara Marin-Camero,Julio Santoyo-Santoyo.Risk factors and classifications of hilar cholangiocarcinoma[J].World Journal of Gastrointestinal Oncology,2013,5(7):132-138. 被引量:23
  • 2Suma L Sangisetty,Thomas J Miner.Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures[J].World Journal of Gastrointestinal Surgery,2012,4(4):87-95. 被引量:45
  • 3E.A. Eisenhauer,P. Therasse,J. Bogaerts,L.H. Schwartz,D. Sargent,R. Ford,J. Dancey,S. Arbuck,S. Gwyther,M. Mooney,L. Rubinstein,L. Shankar,L. Dodd,R. Kaplan,D. Lacombe,J. Verweij.New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)[J]. European Journal of Cancer . 2008 (2)
  • 4P. Katsinelos,J. Kountouras,G. Paroutoglou,G. Chatzimavroudis,C. Zavos.Combination of endoprostheses and oral ursodeoxycholic acid or placebo in the treatment of difficult to extract common bile duct stones[J]. Digestive and Liver Disease . 2007 (6)
  • 5Rebecca L. Siegel,Kimberly D. Miller,Ahmedin Jemal.Cancer statistics, 2015[J]. CA: A Cancer Journal for Clinicians . 2015 (1)
  • 6Davids PH,Groen AK,Rauws EA,et al.Randomised trial of selfexpanding metal stents versus polyethylene stents for distal malignant biliary obstruction. The Lancet . 1992
  • 7T. Seufferlein,J. B. Bachet,E. Van Cutsem.Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology . 2012
  • 8Conroy Thierry,Desseigne Fran?oise,Ychou Marc,Bouché Olivier,Guimbaud Rosine,Bécouarn Yves,Adenis Antoine,Raoul Jean-Luc,Gourgou-Bourgade Sophie,de la Fouchardière Christelle,Bennouna Jaafar,Bachet Jean-Baptiste,Khemissa-Akouz Faiza,Péré.FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. The New England Quarterly . 2011
  • 9Von Hoff DD,Ervin T,Arena FP,Chiorean EG,Infante J,Moore M,Seay T,Tjulandin SA,Ma WW,Saleh MN,Harris M,Reni M,Dowden S,Laheru D,Bahary N,Ramanathan RK,Tabernero J,Hidalgo M,Goldstein D,Van Cutsem E,Wei X,Iglesias J,Renschler MF.Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. The New England Journal of Medicine . 2013
  • 10Phillip S. Ge,Christopher M. Hamerski,Rabindra R. Watson,Srinadh Komanduri,Birtukan B. Cinnor,Kiran Bidari,Jason B. Klapman,Cui L. Lin,Janak N. Shah,Sachin Wani,Timothy R. Donahue,V. Raman Muthusamy.??Plastic biliary stent patency in patients with locally advanced pancreatic adenocarcinoma receiving downstaging chemotherapy(J)Gastrointestinal Endoscopy . 2014

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部